Cargando…
Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity
BACKGROUND: Breast cancer is the leading cause of cancer death in women. Chemotherapy to inhibit the proliferation of cancer cells is considered to be the most important therapeutic strategy. The development of long-circulating PEG and targeting liposomes is a major advance in drug delivery. However...
Autores principales: | Han, Bing, Yang, Yue, Chen, Jinglin, Tang, Huan, Sun, Yuxin, Zhang, Zheng, Wang, Zeng, Li, Yan, Li, Yao, Luan, Xue, Li, Qianwen, Ren, Zhihui, Zhou, Xiaowei, Cong, Dengli, Liu, Zhiyi, Meng, Qin, Sun, Fei, Pei, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986409/ https://www.ncbi.nlm.nih.gov/pubmed/32158208 http://dx.doi.org/10.2147/IJN.S228715 |
Ejemplares similares
-
Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive
por: Han, Bing, et al.
Publicado: (2021) -
Preparation, Pharmacokinetics, Biodistribution, Antitumor Efficacy and Safety of Lx2-32c-Containing Liposome
por: Wang, Hongbo, et al.
Publicado: (2014) -
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017) -
Preparation and pharmacokinetics in vivo of linarin solid dispersion and liposome
por: Huang, Yingying, et al.
Publicado: (2022) -
Codelivery of Doxorubicin and Paclitaxel by Cross-Linked
Multilamellar Liposome Enables Synergistic Antitumor Activity
por: Liu, Yarong, et al.
Publicado: (2014)